Mariia Ivanova transl. Guideline Summary NGC (2016): Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes. KIDNEYS [Internet]. 2021 Sep. 9 [cited 2026 Mar. 16];(4.18):36. Available from: https://kidneysjournal.com/index.php/journal/article/view/137